Home » Topics » Disease categories and therapies » Hematologic

Hematologic
RSS

European Commission grants orphan drug designation to sirolimus for sickle cell disease

Jan. 25, 2018

Imara initiates proof-of-concept phase II study of IMR-687 in sickle cell anemia

Jan. 23, 2018

New phase III trial explores use of BAX-111 in pediatric severe hereditary von Willebrand disease

Jan. 22, 2018

Spark's SPK-8011 given FDA orphan drug status for hemophilia A

Jan. 18, 2018

Darbepoetin alfa biosimilar JR-131 demonstrates equivalence in phase III study

Jan. 18, 2018

Endari now available in U.S. for sickle cell disease in adult and pediatric patients

Jan. 18, 2018

FDA accepts Ruconest sBLA for review

Jan. 17, 2018

Bioverativ conducts phase III trials with BIVV-009 in primary cold agglutinin disease

Jan. 17, 2018

European Commission approves Adynovi for hemophilia A

Jan. 15, 2018

FronThera US Pharmaceuticals presents novel hemoglobin modifier compounds

Jan. 12, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
Sanofi phase III CIDP quit dents Dianthus; C1 mismatch?
BioWorld
Investors in Dianthus Therapeutics Inc. apparently chose to ignore subtleties in the difference between efforts with that firm’s claseprubart vs. those by...
Microbiota modulates the antidepressant effects of GLP-1 analogues
BioWorld Science
Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...